A lead analyst at AMR highlighted that the next-generation sequencing market in Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period.
Download Sample Report:
https://www.linkedin.com/feed/update/urn:li:activity:7006896382770851840
Allied Market Research published a research report on the next-generation sequencing market. The findings of the report state that the global market for next-generation sequencing generated $6.5 billion in 2020, and is projected to reach $35.5 billion by 2030, registering a CAGR of 18.2% from 2021 to 2030. The report offers valuable information on changing market dynamics, major segments, top investment pockets, and competitive scenarios for market players, investors, shareholders, and new entrants.
Get a PDF Sample:
The report provides detailed insights on drivers, restraints, and opportunities to help the market players in devising several growth strategies. The rise in popularity of genome mapping programs, the increase in applications of next-generation sequencing, and the surge in healthcare infrastructure are expected to drive the growth of the global next-generation sequencing market. On the other hand, the lack of skilled professionals is expected to hinder growth to some extent. However, the surge in demand for a rise in application and investment in NGS is expected to offer remunerative opportunities for the growth of the industry.
The report provides a detailed scenario of the impact of the Covid-19 pandemic on the next-generation sequencing market globally. The outbreak of COVID-19 has had a positive impact on the growth of the global next-generation sequencing market due to a significant surge in the number of cases across the globe. NGS was extensively used to determine the genetic sequence of a virus and help scientists understand the change of the virus. Throughout the COVID-19 pandemic, government authorities worldwide are constantly working with the private sector to bring NGS technology the potential diagnostic tool within the market. Thus, the market is expected to grow exponentially in the coming years.
“The rise in technological advancements, especially nanopore sequencing in NGS, and rise in the need to improve diagnostic procedures and ensure quality treatment is propelling the development is propelling the development of next-generation sequencing market,” says Onkar Sumant, Manager, Healthcare at Allied Market Research.
The report offers detailed segmentation of the global next-generation sequencing market based on product, application, technology, end-user, and region. These insights are helpful for new as well as existing market players to capitalize on the fastest-growing and largest revenue-generating segments to accomplish growth in the future.
Based on product type, the consumables segment accounted for more than two-thirds of the total market revenue in 2020, and is projected to rule the roost by the end of 2030. The services segment, on the other hand, would cite the fastest CAGR of 19.3% throughout the forecast period.
Based on application, the biomarkers & cancer segment contributed to more than one-third of the total market share in 2020 and is expected to lead the trail by 2030. The agriculture and animal research segment, on the other hand, is expected to cite the fastest CAGR of 19.2% from 2021 to 2030.
Based on region, the market across North America held the major share in 2020, garnering around two-fifths of the global market. Simultaneously, the market across Asia-Pacific would exhibit the fastest CAGR of 19.0% by 2030. The other two provinces discussed in the report include Europe and LAMEA.
The key players analyzed on the global next-generation sequencing market report include Agilent Technologies, Inc., BGI Group, F. Hoffmann-La Roche AG, Illumina Inc, Precigen Inc., (Intrexon Bioinformatics Germany GmbH), Pacific Biosciences of California, Inc., PerkinElmer, Inc., PierianDx Inc., Qiagen N.V., and Thermo Fisher Scientific Inc.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to offer business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.
Contact us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285 |UK: +44-845-528-1300 | Hong Kong: +852-301-84916 | India (Pune): +91-20-66346060|Fax: +1-855-550-5975
Email: help@alliedmarketresearch.com.
Follow us on LinkedIn, Twitter, Facebook, Pinterest, YouTube & Instagram.